Reversible sclerosing cholangitis secondary to cryptosporidiosis in a renal transplant patient

被引:24
作者
Abdo, A
Klassen, J
Urbanski, S
Raber, E
Swain, MG
机构
[1] Univ Calgary, Hlth Sci Ctr, Dept Med, Calgary, AB T2N 4N1, Canada
[2] Univ Calgary, Dept Pathol, Calgary, AB, Canada
[3] Univ Calgary, Dept Diagnost Imaging, Calgary, AB, Canada
关键词
Cryptosporidium parvum; sclerosing cholangitis; immunosuppression;
D O I
10.1016/S0168-8278(03)00055-2
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Cryptosporidium parvum is a well-known cause of chronic diarrhea. In human immunodeficiency virus (HIV)infected patients as well as in other immunocompromised patients it has also been shown to cause sclerosing cholangitis. We report a case of reversible C. parvum-induced sclerosing cholangitis in a renal transplant patient. This 40-year-old female received a renal transplant 9 years prior to presentation. She had no history of liver disease and was doing well on tacrolimus, prednisone, and azathioprine. She developed diarrhea and was found to have C. parvum present in the stool. Shortly after, she developed clinical, biochemical, radiologic, and histologic features of SC. After accidental reduction in her immunesuppression secondary to starting her on rifampin to treat her itching, she cleared C. parvum from her stool and had a marked improvement in her diarrhea, jaundice, and general health. Her liver enzymes normalized and magnetic resonance cholangiography showed complete resolution of biliary abnormalities. To our knowledge, this is the first case of C. parvum-induced sclerosing cholangitis in a renal transplant patient and one of a few in non-HIV patients. It is also the first to document resolution of sclerosing cholangitis after eradication of C. parvum in a non-HIV patient. (C) 2003 European Association for the Study of the Liver. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:688 / 691
页数:4
相关论文
共 16 条
[1]
Magnetic resonance cholangiography in patients with biliary disease: its role in primary sclerosing cholangitis [J].
Angulo, P ;
Pearce, DH ;
Johnson, CD ;
Henry, JJ ;
LaRusso, NF ;
Petersen, BT ;
Lindor, KD .
JOURNAL OF HEPATOLOGY, 2000, 33 (04) :520-527
[2]
BLANSHARD C, 1985, Q J MED, V307, P813
[3]
Sclerosing cholangitis associated to cryptosporidiosis in liver-transplanted children [J].
Campos, M ;
Jouzdani, E ;
Sempoux, C ;
Buts, JP ;
Reding, R ;
Otte, JB ;
Sokal, EM .
EUROPEAN JOURNAL OF PEDIATRICS, 2000, 159 (1-2) :113-115
[4]
Chieffi P P, 1998, Rev Soc Bras Med Trop, V31, P333, DOI 10.1590/S0037-86821998000400001
[5]
Acquired immunodeficiency syndrome-related cryptosporidial cholangitis:: resolution with endobiliary prosthesis insertion [J].
Cordero, E ;
López-Cortés, LF ;
Belda, O ;
Villanueva, JL ;
Rodríguez-Hernández, MJ ;
Pachón, J .
GASTROINTESTINAL ENDOSCOPY, 2001, 53 (04) :534-535
[6]
HUMAN CRYPTOSPORIDIOSIS IN IMMUNOCOMPETENT AND IMMUNODEFICIENT PERSONS - STUDIES OF AN OUTBREAK AND EXPERIMENTAL TRANSMISSION [J].
CURRENT, WL ;
REESE, NC ;
ERNST, JV ;
BAILEY, WS ;
HEYMAN, MB ;
WEINSTEIN, WM .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (21) :1252-1257
[7]
DAVIS JJ, 1987, AM J GASTROENTEROL, V82, P1196
[8]
USE OF PAROMOMYCIN FOR TREATMENT OF CRYPTOSPORIDIOSIS IN PATIENTS WITH AIDS [J].
FICHTENBAUM, CJ ;
RITCHIE, DJ ;
POWDERLY, WG .
CLINICAL INFECTIOUS DISEASES, 1993, 16 (02) :298-300
[9]
In vitro anticryptosporidial activity of ranalexin alone and in combination with other peptides and with hydrophobic antibiotics [J].
Giacometti, A ;
Cirioni, O ;
Barchiesi, F ;
Fortuna, M ;
Scalise, G .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1999, 18 (11) :827-829
[10]
Cryptosporidiosis of the gastrointestinal tract associated with sclerosing cholangitis in the absence of documented immunodeficiency:: Cryptosporidium parvum and sclerosing cholangitis in an immunocompetent child [J].
Goddard, EA ;
Mouton, SCE ;
Westwood, ATR ;
Ireland, JD ;
Durra, G .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2000, 31 (03) :317-320